In Flux: The Current State of Goodwill & Impairment

As public companies enter the traditional fourth-quarter impairment testing period, two big question marks are hanging over the market…

VRC’s PJ Patel to Present at M&A Science Holiday Virtual Summit

Gain practical valuation modeling insights on identifying and quantifying synergies within the deal model, and with a bit of holiday spirit.

Industry Update: Software

Just released! Read VRC’s latest Industry Update on Software for relevant market data, trends in EBITDA multiples, notable deals and more.

Bloomberg Financial Accounting News Shares Mutarelli’s Post-Q3 Results

In the November issue, Bloomberg publishes Mutarelli’s third-quarter analysis results of valuations and impairment testing, including potential goodwill impairment.

Industry Update: Fire Prevention

Just released! Read VRC’s latest Industry Update on Fire Prevention for relevant market data, trends in EBITDA multiples, notable deals and more.

Jason Mutarelli Published in Bloomberg Tax

Featured in the October issue, Mutarelli analyzes how to approach valuations and impairment testing when managing through the impacts of COVID.

Industry Update: Technology

VRC’s latest Industry Update on Technology was just released! Take a look to learn about relevant trends in EBITDA, market data, multiples, notable deals and more.

Industry Update: Specialty Chemicals

Read VRC’s latest Industry Update on Specialty Chemicals for relevant market data, trends in EBITDA multiples, notable deals and more.

Industry Update: Medical Devices

Just released! VRC’s latest Industry Update on Medical Devices for relevant market data, trends in EBITDA multiples, notable deals and more.

Industry Update: Pharmaceuticals

VRC just released it’s latest Industry Update on Pharmaceuticals! Read more for relevant market data, trends in EBITDA multiples, notable deals and more.